AU9689398A - Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer - Google Patents

Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer

Info

Publication number
AU9689398A
AU9689398A AU96893/98A AU9689398A AU9689398A AU 9689398 A AU9689398 A AU 9689398A AU 96893/98 A AU96893/98 A AU 96893/98A AU 9689398 A AU9689398 A AU 9689398A AU 9689398 A AU9689398 A AU 9689398A
Authority
AU
Australia
Prior art keywords
immunodiagnosis
immunotherapy
compounds
methods
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU96893/98A
Inventor
Davin C. Dillon
Jennifer L. Mitcham
Steven G. Reed
Daniel R. Twardzik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/946,026 external-priority patent/US6034218A/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU9689398A publication Critical patent/AU9689398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU96893/98A 1997-10-07 1998-10-07 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer Abandoned AU9689398A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/946,026 US6034218A (en) 1996-03-15 1997-10-07 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
US08946026 1997-10-07
US10267998A 1998-06-23 1998-06-23
US09102679 1998-06-23
PCT/US1998/021166 WO1999018210A2 (en) 1997-10-07 1998-10-07 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer

Publications (1)

Publication Number Publication Date
AU9689398A true AU9689398A (en) 1999-04-27

Family

ID=26799614

Family Applications (1)

Application Number Title Priority Date Filing Date
AU96893/98A Abandoned AU9689398A (en) 1997-10-07 1998-10-07 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer

Country Status (2)

Country Link
AU (1) AU9689398A (en)
WO (1) WO1999018210A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155952A0 (en) 2000-11-28 2003-12-23 Wyeth Corp Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
BR0115728A (en) 2000-11-28 2003-09-23 Wyeth Corp Analysis of expression of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer.
CA2489623A1 (en) 2001-06-21 2003-01-03 Isis Innovation Limited Atopy
EP2320235A1 (en) * 2009-11-06 2011-05-11 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Marker for prostate cancer diagnosis
EP2320234A1 (en) * 2009-11-06 2011-05-11 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Marker combination for prostate cancer diagnosis
EP2700949A1 (en) 2012-08-24 2014-02-26 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Use of biliverdin reductase proteins as cancer marker
EA201992318A1 (en) * 2017-03-30 2020-03-05 Прогастрин Э Кансер С.А Р.Л. COMPOSITIONS AND METHODS FOR DIAGNOSTIC AND TREATMENT OF PROSTATE CANCER USING A MOLECULE BINDING PROGASTRIN
EP3665277A4 (en) * 2017-08-11 2021-05-12 Tribiotica Llc Methods for generating epitopes for binding to recognition molecules by templated assembly
CN111679074A (en) * 2020-07-11 2020-09-18 成都益安博生物技术有限公司 Prostate cancer peripheral blood TCR marker and detection kit and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990087802A (en) * 1996-03-15 1999-12-27 길리스 스티브 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer

Also Published As

Publication number Publication date
WO1999018210A3 (en) 1999-08-05
WO1999018210A2 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
HUP0002095A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
IL131539A0 (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
NO984229D0 (en) Compounds and Methods for Immunotherapy and Immunodiagnosis of Prostate Cancer
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU6958498A (en) Method for detection of recurrent prostate cancer
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU6949498A (en) Method for assessing prostate cancer
AU1939200A (en) Electrochemical treatment of malignant tumors
AU1610299A (en) Method of cancer cell detection
EP1144632A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU3154297A (en) Materials and methods for detection of breast cancer
AU6148898A (en) 2-substituted 7-haloindenes and methods for synthesizing
AU6468998A (en) Compositions and method for the early diagnosis of ovarian cancer
AU7012496A (en) Compounds and methods for treatment and diagnosis of prostate cancer
AU2292495A (en) Method for molecular staging of prostate cancer
AU3105700A (en) Methods for detection of antiestrogen-resistant breast cancer
AU5005697A (en) Methods of preventing breast cancer
AU2991299A (en) Monoterpenoid derivatives for treatment of cancer
AU8259798A (en) Method for detection of breast cancer
AU9689398A (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
AU9018598A (en) Prognostic compositions for prostate cancer and methods of use thereof
AU5369498A (en) Compounds and methods for treating cancer
AU7832700A (en) Ovarian tumor antigen and methods of use therefor
AU3370095A (en) Methods of inhibiting endometrial cancer
ZA981585B (en) Compounds for immunotherapy of prostate cancer and methods for their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase